Back
Theriva Biologics Vs. SpringWorks Therapeutics Industry Stock Comparison
Sell
20
TOVX
Theriva Biologics
Last Price:
$1.04
Seasonality Move:
-10.33%
Sell
11
SWTX
SpringWorks Therapeutics
Last Price:
$35.75
Seasonality Move:
5.59%
Sell
20
Theriva Biologics (TOVX)
is a Sell
Is Theriva Biologics a Buy, Sell or Hold?
-
The current Theriva Biologics [TOVX] share price is $1.05. The Score for TOVX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
TOVX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
11
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy, Sell or Hold?
-
The current SpringWorks Therapeutics [SWTX] share price is $36.99. The Score for SWTX is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
-
SWTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
TOVX Stock Price Chart
What is Theriva Biologics's stock price today?
-
The Theriva Biologics share price today is $1.05Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TOVX is experiencing slight buying pressure.
SWTX Stock Price Chart
What is SpringWorks Therapeutics's stock price today?
-
The SpringWorks Therapeutics share price today is $36.99Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing slight selling pressure.
TOVX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 35.47 | Sell |
Chaikin Money Flow: | 6175 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.12 - 1.3) | Sell |
Bollinger Bands (100): | (1.18 - 1.58) | Sell |
SWTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.41 | Sell |
Relative Strength Index (14 RSI): | 31.76 | Sell |
Chaikin Money Flow: | -1228444 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.93 - 51.91) | Sell |
Bollinger Bands (100): | (35.17 - 50.17) | Sell |
TOVX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.13 | Sell |
20-day SMA: | 1.18 | Sell |
50-day SMA: | 1.33 | Sell |
200-day SMA: | 2.73 | Sell |
8-day EMA: | 1.13 | Sell |
20-day EMA: | 1.19 | Sell |
50-day EMA: | 1.31 | Sell |
200-day EMA: | 3.32 | Sell |
SWTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43.32 | Sell |
20-day SMA: | 47.1 | Sell |
50-day SMA: | 47.64 | Sell |
200-day SMA: | 39.14 | Sell |
8-day EMA: | 42.51 | Sell |
20-day EMA: | 45.83 | Sell |
50-day EMA: | 46.19 | Sell |
200-day EMA: | 41.19 | Sell |
Theriva Biologics Earnings Growth & TOVX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.60 per share, and a decrease next year of $0.00 per share.
SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $2.06 per share.
Theriva Biologics Technical Analysis
Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
SpringWorks Therapeutics Technical Analysis
Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |